Shaanxi Meibang Pharmaceutical Group Co., Ltd.

Equities

605033

CNE100005071

Agricultural Chemicals

End-of-day quote Shanghai S.E. 18:00:00 2024-07-15 EDT 5-day change 1st Jan Change
11.58 CNY -1.53% Intraday chart for Shaanxi Meibang Pharmaceutical Group Co., Ltd. -0.69% -35.49%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Meibang Pharmaceutical Earmarks 1.4 Billion Yuan for Factory Construction MT
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shaanxi Yatai Testing and Evaluation Co., Ltd. announced that it has received CNY 25 million in funding from Shaanxi Meibang Pharmaceutical Group Co., Ltd. CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shaanxi Yatai Testing and Evaluation Co., Ltd. announced that it expects to receive CNY 25 million in funding from Shaanxi Meibang Pharmaceutical Group Co., Ltd. CI
Shaanxi Meibang Pharma Unit Buys 35.3 Million Yuan Land For Pesticide and Fertilizer Plant MT
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd.(SHSE:605033) added to Shanghai Stock Exchange Composite Index CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd.(SHSE:605033) added to Shanghai Stock Exchange A Share Index CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Shaanxi Meibang Pharmaceutical Group Co., Ltd. has completed an IPO in the amount of CNY 428.922 million. CI
Chart Shaanxi Meibang Pharmaceutical Group Co., Ltd.
More charts
Shaanxi Meibang Pharmaceutical Group Co Ltd is a company mainly engaged in the research and development (R&D), production and sales of pesticide preparations. The Company's products mainly include fungicides and pesticides. The fungicides include 80% dimethylmorpholine water dispersible granules, 27% chunleimycin bromonitrile wettable powder, 72% pyrazole ether ester combined water dispersible granules, 22% chunleimycin chlorobromoisocyanuric acid wettable powder, etc. The insecticides include 21% abamectin benzoate fenitrile suspension, 22% thiamethoxam beta cypermethrin suspension, 45% biphenyl hydrazide ethiconazole suspension, 20% fenitrile bifenthrin suspension, etc.
More about the company
  1. Stock Market
  2. Equities
  3. 605033 Stock
  4. News Shaanxi Meibang Pharmaceutical Group Co., Ltd.
  5. Shaanxi Meibang Pharma Unit Buys 35.3 Million Yuan Land For Pesticide and Fertilizer Plant